nodes	percent_of_prediction	percent_of_DWPC	metapath
Alitretinoin—RARB—lung cancer	0.441	0.87	CbGaD
Alitretinoin—ABCB1—lung cancer	0.0657	0.13	CbGaD
Alitretinoin—ABCB1—Topotecan—lung cancer	0.0202	0.119	CbGbCtD
Alitretinoin—ABCB1—Gefitinib—lung cancer	0.0185	0.109	CbGbCtD
Alitretinoin—ABCB1—Vinorelbine—lung cancer	0.0143	0.0836	CbGbCtD
Alitretinoin—CYP1A2—Erlotinib—lung cancer	0.0125	0.0734	CbGbCtD
Alitretinoin—ABCB1—Crizotinib—lung cancer	0.0113	0.0666	CbGbCtD
Alitretinoin—ABCB1—Gemcitabine—lung cancer	0.0111	0.065	CbGbCtD
Alitretinoin—ABCB1—Erlotinib—lung cancer	0.0109	0.0642	CbGbCtD
Alitretinoin—ABCB1—Paclitaxel—lung cancer	0.01	0.0588	CbGbCtD
Alitretinoin—ABCB1—Irinotecan—lung cancer	0.00988	0.058	CbGbCtD
Alitretinoin—CYP1A2—Etoposide—lung cancer	0.00905	0.0531	CbGbCtD
Alitretinoin—ABCB1—Vinblastine—lung cancer	0.00879	0.0515	CbGbCtD
Alitretinoin—ABCB1—Cisplatin—lung cancer	0.00806	0.0473	CbGbCtD
Alitretinoin—ABCB1—Etoposide—lung cancer	0.00792	0.0464	CbGbCtD
Alitretinoin—ABCB1—Docetaxel—lung cancer	0.00724	0.0425	CbGbCtD
Alitretinoin—ABCB1—Doxorubicin—lung cancer	0.0054	0.0317	CbGbCtD
Alitretinoin—ABCB1—Methotrexate—lung cancer	0.00523	0.0307	CbGbCtD
Alitretinoin—RARA—mammary gland—lung cancer	0.00225	0.0838	CbGeAlD
Alitretinoin—CRABP1—bronchus—lung cancer	0.00199	0.0741	CbGeAlD
Alitretinoin—RARB—respiratory system—lung cancer	0.00195	0.0728	CbGeAlD
Alitretinoin—CRABP2—bronchus—lung cancer	0.0018	0.067	CbGeAlD
Alitretinoin—CRABP1—trachea—lung cancer	0.00178	0.0665	CbGeAlD
Alitretinoin—CRABP2—trachea—lung cancer	0.00161	0.0601	CbGeAlD
Alitretinoin—RARB—bronchus—lung cancer	0.00161	0.0599	CbGeAlD
Alitretinoin—RARG—respiratory system—lung cancer	0.00159	0.0594	CbGeAlD
Alitretinoin—Isotretinoin—RARB—lung cancer	0.00153	0.321	CrCbGaD
Alitretinoin—RARA—respiratory system—lung cancer	0.0015	0.0558	CbGeAlD
Alitretinoin—Acitretin—RARB—lung cancer	0.0013	0.273	CrCbGaD
Alitretinoin—RXRB—cardiac atrium—lung cancer	0.00125	0.0464	CbGeAlD
Alitretinoin—CRABP2—lung—lung cancer	0.00116	0.0432	CbGeAlD
Alitretinoin—RARB—lung—lung cancer	0.00104	0.0386	CbGeAlD
Alitretinoin—RXRB—lung—lung cancer	0.000953	0.0355	CbGeAlD
Alitretinoin—RARA—bone marrow—lung cancer	0.000878	0.0327	CbGeAlD
Alitretinoin—Tretinoin—RARB—lung cancer	0.000877	0.184	CrCbGaD
Alitretinoin—RARG—lung—lung cancer	0.000846	0.0315	CbGeAlD
Alitretinoin—RARA—lung—lung cancer	0.000795	0.0296	CbGeAlD
Alitretinoin—RARB—lymph node—lung cancer	0.000709	0.0264	CbGeAlD
Alitretinoin—RARG—lymph node—lung cancer	0.000578	0.0216	CbGeAlD
Alitretinoin—CYP1A2—respiratory system—lung cancer	0.000555	0.0207	CbGeAlD
Alitretinoin—RARA—lymph node—lung cancer	0.000544	0.0203	CbGeAlD
Alitretinoin—Tretinoin—CYP2A6—lung cancer	0.000351	0.0738	CrCbGaD
Alitretinoin—CYP1A2—lung—lung cancer	0.000295	0.011	CbGeAlD
Alitretinoin—ABCB1—respiratory system—lung cancer	0.000284	0.0106	CbGeAlD
Alitretinoin—Vitamin A—CYP1A1—lung cancer	0.000255	0.0535	CrCbGaD
Alitretinoin—Tretinoin—CYP1A1—lung cancer	0.000246	0.0517	CrCbGaD
Alitretinoin—ABCB1—epithelium—lung cancer	0.000238	0.00886	CbGeAlD
Alitretinoin—ABCB1—trachea—lung cancer	0.00021	0.00784	CbGeAlD
Alitretinoin—Acitretin—ALB—lung cancer	0.000203	0.0426	CrCbGaD
Alitretinoin—ABCB1—bone marrow—lung cancer	0.000167	0.00622	CbGeAlD
Alitretinoin—ABCB1—lung—lung cancer	0.000151	0.00563	CbGeAlD
Alitretinoin—ABCB1—lymph node—lung cancer	0.000103	0.00385	CbGeAlD
Alitretinoin—Haemorrhage—Methotrexate—lung cancer	3.49e-05	0.000187	CcSEcCtD
Alitretinoin—Hepatitis—Methotrexate—lung cancer	3.49e-05	0.000187	CcSEcCtD
Alitretinoin—Pollakiuria—Doxorubicin—lung cancer	3.48e-05	0.000187	CcSEcCtD
Alitretinoin—Asthenia—Gemcitabine—lung cancer	3.47e-05	0.000187	CcSEcCtD
Alitretinoin—Pain—Paclitaxel—lung cancer	3.47e-05	0.000186	CcSEcCtD
Alitretinoin—Constipation—Paclitaxel—lung cancer	3.47e-05	0.000186	CcSEcCtD
Alitretinoin—Confusional state—Docetaxel—lung cancer	3.46e-05	0.000186	CcSEcCtD
Alitretinoin—Pharyngitis—Methotrexate—lung cancer	3.46e-05	0.000186	CcSEcCtD
Alitretinoin—Urinary tract disorder—Methotrexate—lung cancer	3.44e-05	0.000185	CcSEcCtD
Alitretinoin—Photosensitivity reaction—Doxorubicin—lung cancer	3.44e-05	0.000185	CcSEcCtD
Alitretinoin—Anaphylactic shock—Docetaxel—lung cancer	3.44e-05	0.000185	CcSEcCtD
Alitretinoin—Oedema—Docetaxel—lung cancer	3.44e-05	0.000185	CcSEcCtD
Alitretinoin—Weight increased—Doxorubicin—lung cancer	3.43e-05	0.000184	CcSEcCtD
Alitretinoin—Pruritus—Gemcitabine—lung cancer	3.43e-05	0.000184	CcSEcCtD
Alitretinoin—Urethral disorder—Methotrexate—lung cancer	3.42e-05	0.000184	CcSEcCtD
Alitretinoin—Infection—Docetaxel—lung cancer	3.41e-05	0.000183	CcSEcCtD
Alitretinoin—Weight decreased—Doxorubicin—lung cancer	3.41e-05	0.000183	CcSEcCtD
Alitretinoin—Feeling abnormal—Etoposide—lung cancer	3.41e-05	0.000183	CcSEcCtD
Alitretinoin—Diarrhoea—Irinotecan—lung cancer	3.4e-05	0.000183	CcSEcCtD
Alitretinoin—Pneumonia—Doxorubicin—lung cancer	3.38e-05	0.000182	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Etoposide—lung cancer	3.38e-05	0.000182	CcSEcCtD
Alitretinoin—Shock—Docetaxel—lung cancer	3.38e-05	0.000182	CcSEcCtD
Alitretinoin—Nervous system disorder—Docetaxel—lung cancer	3.37e-05	0.000181	CcSEcCtD
Alitretinoin—Thrombocytopenia—Docetaxel—lung cancer	3.36e-05	0.000181	CcSEcCtD
Alitretinoin—Infestation NOS—Doxorubicin—lung cancer	3.36e-05	0.000181	CcSEcCtD
Alitretinoin—Drowsiness—Doxorubicin—lung cancer	3.36e-05	0.000181	CcSEcCtD
Alitretinoin—Infestation—Doxorubicin—lung cancer	3.36e-05	0.000181	CcSEcCtD
Alitretinoin—Visual impairment—Methotrexate—lung cancer	3.36e-05	0.000181	CcSEcCtD
Alitretinoin—Tachycardia—Docetaxel—lung cancer	3.35e-05	0.00018	CcSEcCtD
Alitretinoin—Feeling abnormal—Paclitaxel—lung cancer	3.34e-05	0.00018	CcSEcCtD
Alitretinoin—Skin disorder—Docetaxel—lung cancer	3.34e-05	0.000179	CcSEcCtD
Alitretinoin—Stevens-Johnson syndrome—Doxorubicin—lung cancer	3.33e-05	0.000179	CcSEcCtD
Alitretinoin—Hypersensitivity—Cisplatin—lung cancer	3.32e-05	0.000179	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Paclitaxel—lung cancer	3.31e-05	0.000178	CcSEcCtD
Alitretinoin—Diarrhoea—Gemcitabine—lung cancer	3.31e-05	0.000178	CcSEcCtD
Alitretinoin—Renal failure—Doxorubicin—lung cancer	3.3e-05	0.000178	CcSEcCtD
Alitretinoin—Erythema multiforme—Methotrexate—lung cancer	3.3e-05	0.000177	CcSEcCtD
Alitretinoin—Neuropathy peripheral—Doxorubicin—lung cancer	3.3e-05	0.000177	CcSEcCtD
Alitretinoin—Dizziness—Irinotecan—lung cancer	3.29e-05	0.000177	CcSEcCtD
Alitretinoin—Urticaria—Etoposide—lung cancer	3.28e-05	0.000177	CcSEcCtD
Alitretinoin—Stomatitis—Doxorubicin—lung cancer	3.28e-05	0.000176	CcSEcCtD
Alitretinoin—Anorexia—Docetaxel—lung cancer	3.27e-05	0.000176	CcSEcCtD
Alitretinoin—Abdominal pain—Etoposide—lung cancer	3.27e-05	0.000176	CcSEcCtD
Alitretinoin—Body temperature increased—Etoposide—lung cancer	3.27e-05	0.000176	CcSEcCtD
Alitretinoin—Conjunctivitis—Doxorubicin—lung cancer	3.27e-05	0.000176	CcSEcCtD
Alitretinoin—Urinary tract infection—Doxorubicin—lung cancer	3.27e-05	0.000176	CcSEcCtD
Alitretinoin—Eye disorder—Methotrexate—lung cancer	3.26e-05	0.000175	CcSEcCtD
Alitretinoin—Tinnitus—Methotrexate—lung cancer	3.25e-05	0.000175	CcSEcCtD
Alitretinoin—Asthenia—Cisplatin—lung cancer	3.24e-05	0.000174	CcSEcCtD
Alitretinoin—Sweating—Doxorubicin—lung cancer	3.22e-05	0.000173	CcSEcCtD
Alitretinoin—Urticaria—Paclitaxel—lung cancer	3.22e-05	0.000173	CcSEcCtD
Alitretinoin—Hypotension—Docetaxel—lung cancer	3.21e-05	0.000173	CcSEcCtD
Alitretinoin—Haematuria—Doxorubicin—lung cancer	3.21e-05	0.000172	CcSEcCtD
Alitretinoin—Abdominal pain—Paclitaxel—lung cancer	3.2e-05	0.000172	CcSEcCtD
Alitretinoin—Body temperature increased—Paclitaxel—lung cancer	3.2e-05	0.000172	CcSEcCtD
Alitretinoin—Epistaxis—Doxorubicin—lung cancer	3.17e-05	0.00017	CcSEcCtD
Alitretinoin—Angiopathy—Methotrexate—lung cancer	3.16e-05	0.00017	CcSEcCtD
Alitretinoin—Vomiting—Irinotecan—lung cancer	3.16e-05	0.00017	CcSEcCtD
Alitretinoin—Sinusitis—Doxorubicin—lung cancer	3.15e-05	0.00017	CcSEcCtD
Alitretinoin—Agranulocytosis—Doxorubicin—lung cancer	3.14e-05	0.000169	CcSEcCtD
Alitretinoin—Rash—Irinotecan—lung cancer	3.13e-05	0.000168	CcSEcCtD
Alitretinoin—Dermatitis—Irinotecan—lung cancer	3.13e-05	0.000168	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Docetaxel—lung cancer	3.13e-05	0.000168	CcSEcCtD
Alitretinoin—Chills—Methotrexate—lung cancer	3.13e-05	0.000168	CcSEcCtD
Alitretinoin—Headache—Irinotecan—lung cancer	3.11e-05	0.000167	CcSEcCtD
Alitretinoin—Insomnia—Docetaxel—lung cancer	3.11e-05	0.000167	CcSEcCtD
Alitretinoin—Diarrhoea—Cisplatin—lung cancer	3.09e-05	0.000166	CcSEcCtD
Alitretinoin—Paraesthesia—Docetaxel—lung cancer	3.09e-05	0.000166	CcSEcCtD
Alitretinoin—Alopecia—Methotrexate—lung cancer	3.08e-05	0.000166	CcSEcCtD
Alitretinoin—Vomiting—Gemcitabine—lung cancer	3.08e-05	0.000165	CcSEcCtD
Alitretinoin—Dyspnoea—Docetaxel—lung cancer	3.06e-05	0.000165	CcSEcCtD
Alitretinoin—Somnolence—Docetaxel—lung cancer	3.05e-05	0.000164	CcSEcCtD
Alitretinoin—Mental disorder—Methotrexate—lung cancer	3.05e-05	0.000164	CcSEcCtD
Alitretinoin—Rash—Gemcitabine—lung cancer	3.05e-05	0.000164	CcSEcCtD
Alitretinoin—Dermatitis—Gemcitabine—lung cancer	3.05e-05	0.000164	CcSEcCtD
Alitretinoin—Hypersensitivity—Etoposide—lung cancer	3.05e-05	0.000164	CcSEcCtD
Alitretinoin—Malnutrition—Methotrexate—lung cancer	3.03e-05	0.000163	CcSEcCtD
Alitretinoin—Erythema—Methotrexate—lung cancer	3.03e-05	0.000163	CcSEcCtD
Alitretinoin—Haemoglobin—Doxorubicin—lung cancer	3.03e-05	0.000163	CcSEcCtD
Alitretinoin—Headache—Gemcitabine—lung cancer	3.03e-05	0.000163	CcSEcCtD
Alitretinoin—Dyspepsia—Docetaxel—lung cancer	3.02e-05	0.000163	CcSEcCtD
Alitretinoin—Hepatitis—Doxorubicin—lung cancer	3.02e-05	0.000162	CcSEcCtD
Alitretinoin—Haemorrhage—Doxorubicin—lung cancer	3.02e-05	0.000162	CcSEcCtD
Alitretinoin—Hypoaesthesia—Doxorubicin—lung cancer	3e-05	0.000161	CcSEcCtD
Alitretinoin—Pharyngitis—Doxorubicin—lung cancer	3e-05	0.000161	CcSEcCtD
Alitretinoin—Decreased appetite—Docetaxel—lung cancer	2.99e-05	0.000161	CcSEcCtD
Alitretinoin—Hypersensitivity—Paclitaxel—lung cancer	2.99e-05	0.000161	CcSEcCtD
Alitretinoin—Urinary tract disorder—Doxorubicin—lung cancer	2.98e-05	0.00016	CcSEcCtD
Alitretinoin—Oedema peripheral—Doxorubicin—lung cancer	2.97e-05	0.00016	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Docetaxel—lung cancer	2.97e-05	0.000159	CcSEcCtD
Alitretinoin—Asthenia—Etoposide—lung cancer	2.97e-05	0.000159	CcSEcCtD
Alitretinoin—Fatigue—Docetaxel—lung cancer	2.96e-05	0.000159	CcSEcCtD
Alitretinoin—Urethral disorder—Doxorubicin—lung cancer	2.96e-05	0.000159	CcSEcCtD
Alitretinoin—Nausea—Irinotecan—lung cancer	2.95e-05	0.000159	CcSEcCtD
Alitretinoin—Constipation—Docetaxel—lung cancer	2.94e-05	0.000158	CcSEcCtD
Alitretinoin—Pain—Docetaxel—lung cancer	2.94e-05	0.000158	CcSEcCtD
Alitretinoin—Back pain—Methotrexate—lung cancer	2.93e-05	0.000158	CcSEcCtD
Alitretinoin—Pruritus—Etoposide—lung cancer	2.92e-05	0.000157	CcSEcCtD
Alitretinoin—Visual impairment—Doxorubicin—lung cancer	2.91e-05	0.000156	CcSEcCtD
Alitretinoin—Asthenia—Paclitaxel—lung cancer	2.91e-05	0.000156	CcSEcCtD
Alitretinoin—Nausea—Gemcitabine—lung cancer	2.88e-05	0.000155	CcSEcCtD
Alitretinoin—Vomiting—Cisplatin—lung cancer	2.87e-05	0.000154	CcSEcCtD
Alitretinoin—Pruritus—Paclitaxel—lung cancer	2.87e-05	0.000154	CcSEcCtD
Alitretinoin—Vision blurred—Methotrexate—lung cancer	2.86e-05	0.000154	CcSEcCtD
Alitretinoin—Erythema multiforme—Doxorubicin—lung cancer	2.85e-05	0.000153	CcSEcCtD
Alitretinoin—Rash—Cisplatin—lung cancer	2.85e-05	0.000153	CcSEcCtD
Alitretinoin—Dermatitis—Cisplatin—lung cancer	2.84e-05	0.000153	CcSEcCtD
Alitretinoin—Feeling abnormal—Docetaxel—lung cancer	2.83e-05	0.000152	CcSEcCtD
Alitretinoin—Diarrhoea—Etoposide—lung cancer	2.83e-05	0.000152	CcSEcCtD
Alitretinoin—Eye disorder—Doxorubicin—lung cancer	2.82e-05	0.000152	CcSEcCtD
Alitretinoin—Ill-defined disorder—Methotrexate—lung cancer	2.82e-05	0.000151	CcSEcCtD
Alitretinoin—Tinnitus—Doxorubicin—lung cancer	2.81e-05	0.000151	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Docetaxel—lung cancer	2.81e-05	0.000151	CcSEcCtD
Alitretinoin—Anaemia—Methotrexate—lung cancer	2.8e-05	0.000151	CcSEcCtD
Alitretinoin—Flushing—Doxorubicin—lung cancer	2.8e-05	0.000151	CcSEcCtD
Alitretinoin—Diarrhoea—Paclitaxel—lung cancer	2.77e-05	0.000149	CcSEcCtD
Alitretinoin—Angiopathy—Doxorubicin—lung cancer	2.74e-05	0.000147	CcSEcCtD
Alitretinoin—Malaise—Methotrexate—lung cancer	2.74e-05	0.000147	CcSEcCtD
Alitretinoin—Dizziness—Etoposide—lung cancer	2.73e-05	0.000147	CcSEcCtD
Alitretinoin—Abdominal pain—Docetaxel—lung cancer	2.72e-05	0.000146	CcSEcCtD
Alitretinoin—Body temperature increased—Docetaxel—lung cancer	2.72e-05	0.000146	CcSEcCtD
Alitretinoin—Chills—Doxorubicin—lung cancer	2.71e-05	0.000146	CcSEcCtD
Alitretinoin—Arrhythmia—Doxorubicin—lung cancer	2.7e-05	0.000145	CcSEcCtD
Alitretinoin—Dizziness—Paclitaxel—lung cancer	2.68e-05	0.000144	CcSEcCtD
Alitretinoin—Nausea—Cisplatin—lung cancer	2.68e-05	0.000144	CcSEcCtD
Alitretinoin—Alopecia—Doxorubicin—lung cancer	2.67e-05	0.000143	CcSEcCtD
Alitretinoin—Cough—Methotrexate—lung cancer	2.65e-05	0.000142	CcSEcCtD
Alitretinoin—Mental disorder—Doxorubicin—lung cancer	2.64e-05	0.000142	CcSEcCtD
Alitretinoin—Convulsion—Methotrexate—lung cancer	2.63e-05	0.000141	CcSEcCtD
Alitretinoin—Vomiting—Etoposide—lung cancer	2.63e-05	0.000141	CcSEcCtD
Alitretinoin—Erythema—Doxorubicin—lung cancer	2.63e-05	0.000141	CcSEcCtD
Alitretinoin—Malnutrition—Doxorubicin—lung cancer	2.63e-05	0.000141	CcSEcCtD
Alitretinoin—Rash—Etoposide—lung cancer	2.61e-05	0.00014	CcSEcCtD
Alitretinoin—Dermatitis—Etoposide—lung cancer	2.6e-05	0.00014	CcSEcCtD
Alitretinoin—Headache—Etoposide—lung cancer	2.59e-05	0.000139	CcSEcCtD
Alitretinoin—Flatulence—Doxorubicin—lung cancer	2.59e-05	0.000139	CcSEcCtD
Alitretinoin—Arthralgia—Methotrexate—lung cancer	2.58e-05	0.000139	CcSEcCtD
Alitretinoin—Chest pain—Methotrexate—lung cancer	2.58e-05	0.000139	CcSEcCtD
Alitretinoin—Myalgia—Methotrexate—lung cancer	2.58e-05	0.000139	CcSEcCtD
Alitretinoin—Tension—Doxorubicin—lung cancer	2.58e-05	0.000139	CcSEcCtD
Alitretinoin—Vomiting—Paclitaxel—lung cancer	2.58e-05	0.000139	CcSEcCtD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	2.57e-05	0.000138	CcSEcCtD
Alitretinoin—Rash—Paclitaxel—lung cancer	2.56e-05	0.000137	CcSEcCtD
Alitretinoin—Dermatitis—Paclitaxel—lung cancer	2.55e-05	0.000137	CcSEcCtD
Alitretinoin—Discomfort—Methotrexate—lung cancer	2.55e-05	0.000137	CcSEcCtD
Alitretinoin—Nervousness—Doxorubicin—lung cancer	2.55e-05	0.000137	CcSEcCtD
Alitretinoin—Back pain—Doxorubicin—lung cancer	2.54e-05	0.000137	CcSEcCtD
Alitretinoin—Headache—Paclitaxel—lung cancer	2.54e-05	0.000136	CcSEcCtD
Alitretinoin—Hypersensitivity—Docetaxel—lung cancer	2.53e-05	0.000136	CcSEcCtD
Alitretinoin—Confusional state—Methotrexate—lung cancer	2.5e-05	0.000134	CcSEcCtD
Alitretinoin—Anaphylactic shock—Methotrexate—lung cancer	2.48e-05	0.000133	CcSEcCtD
Alitretinoin—Vision blurred—Doxorubicin—lung cancer	2.48e-05	0.000133	CcSEcCtD
Alitretinoin—Asthenia—Docetaxel—lung cancer	2.47e-05	0.000132	CcSEcCtD
Alitretinoin—Infection—Methotrexate—lung cancer	2.46e-05	0.000132	CcSEcCtD
Alitretinoin—Nausea—Etoposide—lung cancer	2.46e-05	0.000132	CcSEcCtD
Alitretinoin—Ill-defined disorder—Doxorubicin—lung cancer	2.44e-05	0.000131	CcSEcCtD
Alitretinoin—Pruritus—Docetaxel—lung cancer	2.43e-05	0.000131	CcSEcCtD
Alitretinoin—Nervous system disorder—Methotrexate—lung cancer	2.43e-05	0.000131	CcSEcCtD
Alitretinoin—Anaemia—Doxorubicin—lung cancer	2.43e-05	0.000131	CcSEcCtD
Alitretinoin—Thrombocytopenia—Methotrexate—lung cancer	2.42e-05	0.00013	CcSEcCtD
Alitretinoin—Agitation—Doxorubicin—lung cancer	2.41e-05	0.00013	CcSEcCtD
Alitretinoin—Nausea—Paclitaxel—lung cancer	2.41e-05	0.000129	CcSEcCtD
Alitretinoin—Skin disorder—Methotrexate—lung cancer	2.41e-05	0.000129	CcSEcCtD
Alitretinoin—Hyperhidrosis—Methotrexate—lung cancer	2.39e-05	0.000129	CcSEcCtD
Alitretinoin—Malaise—Doxorubicin—lung cancer	2.37e-05	0.000127	CcSEcCtD
Alitretinoin—Anorexia—Methotrexate—lung cancer	2.36e-05	0.000127	CcSEcCtD
Alitretinoin—Syncope—Doxorubicin—lung cancer	2.36e-05	0.000127	CcSEcCtD
Alitretinoin—Diarrhoea—Docetaxel—lung cancer	2.35e-05	0.000126	CcSEcCtD
Alitretinoin—Palpitations—Doxorubicin—lung cancer	2.32e-05	0.000125	CcSEcCtD
Alitretinoin—Hypotension—Methotrexate—lung cancer	2.31e-05	0.000124	CcSEcCtD
Alitretinoin—Loss of consciousness—Doxorubicin—lung cancer	2.31e-05	0.000124	CcSEcCtD
Alitretinoin—Cough—Doxorubicin—lung cancer	2.29e-05	0.000123	CcSEcCtD
Alitretinoin—Convulsion—Doxorubicin—lung cancer	2.28e-05	0.000122	CcSEcCtD
Alitretinoin—Dizziness—Docetaxel—lung cancer	2.27e-05	0.000122	CcSEcCtD
Alitretinoin—Hypertension—Doxorubicin—lung cancer	2.27e-05	0.000122	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Methotrexate—lung cancer	2.26e-05	0.000121	CcSEcCtD
Alitretinoin—Insomnia—Methotrexate—lung cancer	2.24e-05	0.00012	CcSEcCtD
Alitretinoin—Myalgia—Doxorubicin—lung cancer	2.24e-05	0.00012	CcSEcCtD
Alitretinoin—Arthralgia—Doxorubicin—lung cancer	2.24e-05	0.00012	CcSEcCtD
Alitretinoin—Chest pain—Doxorubicin—lung cancer	2.24e-05	0.00012	CcSEcCtD
Alitretinoin—Anxiety—Doxorubicin—lung cancer	2.23e-05	0.00012	CcSEcCtD
Alitretinoin—Paraesthesia—Methotrexate—lung cancer	2.22e-05	0.00012	CcSEcCtD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	2.22e-05	0.000119	CcSEcCtD
Alitretinoin—Discomfort—Doxorubicin—lung cancer	2.21e-05	0.000119	CcSEcCtD
Alitretinoin—Dyspnoea—Methotrexate—lung cancer	2.21e-05	0.000119	CcSEcCtD
Alitretinoin—Somnolence—Methotrexate—lung cancer	2.2e-05	0.000118	CcSEcCtD
Alitretinoin—Dry mouth—Doxorubicin—lung cancer	2.19e-05	0.000118	CcSEcCtD
Alitretinoin—Vomiting—Docetaxel—lung cancer	2.18e-05	0.000117	CcSEcCtD
Alitretinoin—Dyspepsia—Methotrexate—lung cancer	2.18e-05	0.000117	CcSEcCtD
Alitretinoin—Rash—Docetaxel—lung cancer	2.17e-05	0.000116	CcSEcCtD
Alitretinoin—Dermatitis—Docetaxel—lung cancer	2.16e-05	0.000116	CcSEcCtD
Alitretinoin—Confusional state—Doxorubicin—lung cancer	2.16e-05	0.000116	CcSEcCtD
Alitretinoin—Decreased appetite—Methotrexate—lung cancer	2.15e-05	0.000116	CcSEcCtD
Alitretinoin—Headache—Docetaxel—lung cancer	2.15e-05	0.000116	CcSEcCtD
Alitretinoin—Oedema—Doxorubicin—lung cancer	2.14e-05	0.000115	CcSEcCtD
Alitretinoin—Anaphylactic shock—Doxorubicin—lung cancer	2.14e-05	0.000115	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Methotrexate—lung cancer	2.14e-05	0.000115	CcSEcCtD
Alitretinoin—Fatigue—Methotrexate—lung cancer	2.13e-05	0.000115	CcSEcCtD
Alitretinoin—Infection—Doxorubicin—lung cancer	2.13e-05	0.000114	CcSEcCtD
Alitretinoin—Pain—Methotrexate—lung cancer	2.12e-05	0.000114	CcSEcCtD
Alitretinoin—Shock—Doxorubicin—lung cancer	2.11e-05	0.000113	CcSEcCtD
Alitretinoin—Nervous system disorder—Doxorubicin—lung cancer	2.1e-05	0.000113	CcSEcCtD
Alitretinoin—Thrombocytopenia—Doxorubicin—lung cancer	2.1e-05	0.000113	CcSEcCtD
Alitretinoin—Tachycardia—Doxorubicin—lung cancer	2.09e-05	0.000112	CcSEcCtD
Alitretinoin—Skin disorder—Doxorubicin—lung cancer	2.08e-05	0.000112	CcSEcCtD
Alitretinoin—Hyperhidrosis—Doxorubicin—lung cancer	2.07e-05	0.000111	CcSEcCtD
Alitretinoin—Anorexia—Doxorubicin—lung cancer	2.04e-05	0.00011	CcSEcCtD
Alitretinoin—Nausea—Docetaxel—lung cancer	2.04e-05	0.00011	CcSEcCtD
Alitretinoin—Feeling abnormal—Methotrexate—lung cancer	2.04e-05	0.00011	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Methotrexate—lung cancer	2.02e-05	0.000109	CcSEcCtD
Alitretinoin—Hypotension—Doxorubicin—lung cancer	2e-05	0.000108	CcSEcCtD
Alitretinoin—Urticaria—Methotrexate—lung cancer	1.97e-05	0.000106	CcSEcCtD
Alitretinoin—Abdominal pain—Methotrexate—lung cancer	1.96e-05	0.000105	CcSEcCtD
Alitretinoin—Body temperature increased—Methotrexate—lung cancer	1.96e-05	0.000105	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Doxorubicin—lung cancer	1.95e-05	0.000105	CcSEcCtD
Alitretinoin—Insomnia—Doxorubicin—lung cancer	1.94e-05	0.000104	CcSEcCtD
Alitretinoin—Paraesthesia—Doxorubicin—lung cancer	1.93e-05	0.000103	CcSEcCtD
Alitretinoin—Dyspnoea—Doxorubicin—lung cancer	1.91e-05	0.000103	CcSEcCtD
Alitretinoin—Somnolence—Doxorubicin—lung cancer	1.91e-05	0.000102	CcSEcCtD
Alitretinoin—Dyspepsia—Doxorubicin—lung cancer	1.89e-05	0.000101	CcSEcCtD
Alitretinoin—Decreased appetite—Doxorubicin—lung cancer	1.86e-05	0.0001	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Doxorubicin—lung cancer	1.85e-05	9.95e-05	CcSEcCtD
Alitretinoin—Fatigue—Doxorubicin—lung cancer	1.85e-05	9.94e-05	CcSEcCtD
Alitretinoin—Pain—Doxorubicin—lung cancer	1.83e-05	9.86e-05	CcSEcCtD
Alitretinoin—Constipation—Doxorubicin—lung cancer	1.83e-05	9.86e-05	CcSEcCtD
Alitretinoin—Hypersensitivity—Methotrexate—lung cancer	1.82e-05	9.81e-05	CcSEcCtD
Alitretinoin—Asthenia—Methotrexate—lung cancer	1.78e-05	9.55e-05	CcSEcCtD
Alitretinoin—Feeling abnormal—Doxorubicin—lung cancer	1.77e-05	9.5e-05	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Doxorubicin—lung cancer	1.75e-05	9.42e-05	CcSEcCtD
Alitretinoin—Pruritus—Methotrexate—lung cancer	1.75e-05	9.42e-05	CcSEcCtD
Alitretinoin—Urticaria—Doxorubicin—lung cancer	1.7e-05	9.16e-05	CcSEcCtD
Alitretinoin—Abdominal pain—Doxorubicin—lung cancer	1.7e-05	9.11e-05	CcSEcCtD
Alitretinoin—Body temperature increased—Doxorubicin—lung cancer	1.7e-05	9.11e-05	CcSEcCtD
Alitretinoin—Diarrhoea—Methotrexate—lung cancer	1.69e-05	9.11e-05	CcSEcCtD
Alitretinoin—Dizziness—Methotrexate—lung cancer	1.64e-05	8.8e-05	CcSEcCtD
Alitretinoin—Hypersensitivity—Doxorubicin—lung cancer	1.58e-05	8.49e-05	CcSEcCtD
Alitretinoin—Vomiting—Methotrexate—lung cancer	1.57e-05	8.46e-05	CcSEcCtD
Alitretinoin—Rash—Methotrexate—lung cancer	1.56e-05	8.39e-05	CcSEcCtD
Alitretinoin—Dermatitis—Methotrexate—lung cancer	1.56e-05	8.38e-05	CcSEcCtD
Alitretinoin—Headache—Methotrexate—lung cancer	1.55e-05	8.34e-05	CcSEcCtD
Alitretinoin—Asthenia—Doxorubicin—lung cancer	1.54e-05	8.27e-05	CcSEcCtD
Alitretinoin—RXRA—Metabolism—NCOA3—lung cancer	1.52e-05	0.000144	CbGpPWpGaD
Alitretinoin—Pruritus—Doxorubicin—lung cancer	1.52e-05	8.15e-05	CcSEcCtD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.49e-05	0.000141	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—JUNB—lung cancer	1.49e-05	0.000141	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ATP5H—lung cancer	1.48e-05	0.00014	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—MMP2—lung cancer	1.48e-05	0.00014	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—MAP2K1—lung cancer	1.48e-05	0.00014	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—ADCY1—lung cancer	1.48e-05	0.00014	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—ABCG2—lung cancer	1.48e-05	0.00014	CbGpPWpGaD
Alitretinoin—Nausea—Methotrexate—lung cancer	1.47e-05	7.91e-05	CcSEcCtD
Alitretinoin—Diarrhoea—Doxorubicin—lung cancer	1.47e-05	7.89e-05	CcSEcCtD
Alitretinoin—CRABP1—Metabolism—PTEN—lung cancer	1.45e-05	0.000137	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—PTEN—lung cancer	1.45e-05	0.000137	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—HPGDS—lung cancer	1.45e-05	0.000137	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—ENO2—lung cancer	1.45e-05	0.000137	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PPP2R1B—lung cancer	1.44e-05	0.000136	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—APC—lung cancer	1.43e-05	0.000135	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.42e-05	0.000134	CbGpPWpGaD
Alitretinoin—Dizziness—Doxorubicin—lung cancer	1.42e-05	7.62e-05	CcSEcCtD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—lung cancer	1.41e-05	0.000133	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—GSTT1—lung cancer	1.4e-05	0.000133	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—GNG11—lung cancer	1.4e-05	0.000133	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—AZIN2—lung cancer	1.39e-05	0.000132	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—COL4A3BP—lung cancer	1.39e-05	0.000132	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—GCLC—lung cancer	1.39e-05	0.000131	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—CYP2A6—lung cancer	1.39e-05	0.000131	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—EP300—lung cancer	1.38e-05	0.000131	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—EP300—lung cancer	1.38e-05	0.000131	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.38e-05	0.000131	CbGpPWpGaD
Alitretinoin—Vomiting—Doxorubicin—lung cancer	1.36e-05	7.33e-05	CcSEcCtD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	1.36e-05	0.000129	CbGpPWpGaD
Alitretinoin—Rash—Doxorubicin—lung cancer	1.35e-05	7.27e-05	CcSEcCtD
Alitretinoin—Dermatitis—Doxorubicin—lung cancer	1.35e-05	7.26e-05	CcSEcCtD
Alitretinoin—Headache—Doxorubicin—lung cancer	1.34e-05	7.22e-05	CcSEcCtD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—lung cancer	1.33e-05	0.000126	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—lung cancer	1.32e-05	0.000125	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PLBD1—lung cancer	1.32e-05	0.000125	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—ENO1—lung cancer	1.32e-05	0.000125	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—CREBBP—lung cancer	1.31e-05	0.000124	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.31e-05	0.000124	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—RAF1—lung cancer	1.31e-05	0.000124	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—ABCC3—lung cancer	1.3e-05	0.000123	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—ERBB2—lung cancer	1.3e-05	0.000123	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.29e-05	0.000122	CbGpPWpGaD
Alitretinoin—ABCB1—HIF-1-alpha transcription factor network—AKT1—lung cancer	1.27e-05	0.000121	CbGpPWpGaD
Alitretinoin—Nausea—Doxorubicin—lung cancer	1.27e-05	6.85e-05	CcSEcCtD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—lung cancer	1.26e-05	0.00012	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—ADCY1—lung cancer	1.26e-05	0.000119	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—ABCG2—lung cancer	1.26e-05	0.000119	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	1.26e-05	0.000119	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—ALB—lung cancer	1.23e-05	0.000116	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—HSD17B10—lung cancer	1.21e-05	0.000114	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ATP5H—lung cancer	1.18e-05	0.000112	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—CYP2E1—lung cancer	1.18e-05	0.000112	CbGpPWpGaD
Alitretinoin—CYP1A2—Biological oxidations—POMC—lung cancer	1.18e-05	0.000112	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—TF—lung cancer	1.17e-05	0.000111	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—NQO1—lung cancer	1.17e-05	0.00011	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.14e-05	0.000108	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.13e-05	0.000107	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—lung cancer	1.12e-05	0.000106	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CKB—lung cancer	1.12e-05	0.000106	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—lung cancer	1.12e-05	0.000106	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—RAF1—lung cancer	1.11e-05	0.000105	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—MMP9—lung cancer	1.11e-05	0.000105	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—lung cancer	1.11e-05	0.000105	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	1.09e-05	0.000103	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—lung cancer	1.08e-05	0.000103	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—ERCC2—lung cancer	1.08e-05	0.000102	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—MAPK3—lung cancer	1.08e-05	0.000102	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GSTM2—lung cancer	1.06e-05	9.99e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CNDP2—lung cancer	1.06e-05	9.99e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PLBD1—lung cancer	1.05e-05	9.98e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—EP300—lung cancer	1.05e-05	9.98e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—STK11—lung cancer	1.05e-05	9.95e-05	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—MYC—lung cancer	1.05e-05	9.92e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	1.04e-05	9.81e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—MTMR3—lung cancer	1.03e-05	9.72e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—SRC—lung cancer	1.02e-05	9.7e-05	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—PIK3CA—lung cancer	1.02e-05	9.7e-05	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—PIK3CA—lung cancer	1.02e-05	9.7e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—lung cancer	1.01e-05	9.52e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PGAM1—lung cancer	1e-05	9.47e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—VEGFA—lung cancer	9.98e-06	9.45e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—STAT3—lung cancer	9.88e-06	9.36e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PTEN—lung cancer	9.87e-06	9.34e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—NRAS—lung cancer	9.86e-06	9.33e-05	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—MAPK3—lung cancer	9.86e-06	9.33e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—lung cancer	9.79e-06	9.26e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—lung cancer	9.77e-06	9.24e-05	CbGpPWpGaD
Alitretinoin—RXRA—Generic Transcription Pathway—MYC—lung cancer	9.76e-06	9.24e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—GSTP1—lung cancer	9.73e-06	9.21e-05	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—MAPK3—lung cancer	9.67e-06	9.15e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—HSD17B10—lung cancer	9.64e-06	9.13e-05	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—MYC—lung cancer	9.59e-06	9.08e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CYP2A7—lung cancer	9.55e-06	9.04e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—lung cancer	9.47e-06	8.96e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—CAT—lung cancer	9.47e-06	8.96e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—lung cancer	9.45e-06	8.94e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—MAPK3—lung cancer	9.44e-06	8.94e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—EP300—lung cancer	9.41e-06	8.91e-05	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—MYC—lung cancer	9.4e-06	8.9e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—SDC4—lung cancer	9.34e-06	8.84e-05	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—MAPK3—lung cancer	9.27e-06	8.77e-05	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—MAPK3—lung cancer	9.27e-06	8.77e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—ABCB1—lung cancer	9.21e-06	8.72e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—TYMS—lung cancer	9.05e-06	8.56e-05	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—MYC—lung cancer	9.01e-06	8.53e-05	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—MYC—lung cancer	9.01e-06	8.53e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—lung cancer	9.01e-06	8.53e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—EGFR—lung cancer	8.98e-06	8.5e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CKB—lung cancer	8.96e-06	8.48e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—GSTM1—lung cancer	8.94e-06	8.46e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—lung cancer	8.76e-06	8.29e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	8.53e-06	8.08e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—RRM1—lung cancer	8.51e-06	8.05e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GSTA3—lung cancer	8.51e-06	8.05e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—KRAS—lung cancer	8.49e-06	8.03e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—CYP1A1—lung cancer	8.48e-06	8.02e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CNDP2—lung cancer	8.43e-06	7.98e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GSTM2—lung cancer	8.43e-06	7.98e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—ERCC2—lung cancer	8.41e-06	7.96e-05	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—AKT1—lung cancer	8.37e-06	7.92e-05	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—AKT1—lung cancer	8.37e-06	7.92e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—MTMR3—lung cancer	8.2e-06	7.76e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—AVP—lung cancer	8.11e-06	7.68e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	8.07e-06	7.64e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—B4GALT5—lung cancer	8e-06	7.57e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PGAM1—lung cancer	7.99e-06	7.56e-05	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—CREBBP—lung cancer	7.92e-06	7.49e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	7.85e-06	7.43e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GSTA4—lung cancer	7.78e-06	7.37e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	7.68e-06	7.27e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CYP2A7—lung cancer	7.62e-06	7.21e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GSTA2—lung cancer	7.58e-06	7.18e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—SDC4—lung cancer	7.46e-06	7.06e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GSTA1—lung cancer	7.32e-06	6.93e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—APOA1—lung cancer	7.27e-06	6.88e-05	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—AKT1—lung cancer	7.27e-06	6.88e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	7.25e-06	6.87e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ABCC3—lung cancer	7.23e-06	6.85e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—HRAS—lung cancer	7.21e-06	6.83e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—AKR1C1—lung cancer	7.01e-06	6.63e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	6.96e-06	6.59e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—IL6—lung cancer	6.9e-06	6.54e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—UGT1A1—lung cancer	6.8e-06	6.44e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—RRM1—lung cancer	6.79e-06	6.43e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GSTA3—lung cancer	6.79e-06	6.43e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	6.66e-06	6.31e-05	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—AKT1—lung cancer	6.65e-06	6.29e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PIK3CG—lung cancer	6.64e-06	6.28e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GNG11—lung cancer	6.56e-06	6.21e-05	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—AKT1—lung cancer	6.52e-06	6.17e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	6.45e-06	6.1e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—B4GALT5—lung cancer	6.39e-06	6.04e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—AKT1—lung cancer	6.37e-06	6.03e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—POMC—lung cancer	6.32e-06	5.98e-05	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—AKT1—lung cancer	6.25e-06	5.92e-05	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—AKT1—lung cancer	6.25e-06	5.92e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ALDOA—lung cancer	6.25e-06	5.91e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GSTA4—lung cancer	6.21e-06	5.88e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—APOA1—lung cancer	6.2e-06	5.87e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—CREBBP—lung cancer	6.16e-06	5.83e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	6.07e-06	5.75e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—NCOA3—lung cancer	6.06e-06	5.74e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GSTA2—lung cancer	6.05e-06	5.73e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ABCG2—lung cancer	5.9e-06	5.58e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ADCY1—lung cancer	5.9e-06	5.58e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GSTA1—lung cancer	5.84e-06	5.53e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PIK3CD—lung cancer	5.84e-06	5.52e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—HPGDS—lung cancer	5.78e-06	5.47e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ENO2—lung cancer	5.78e-06	5.47e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ABCC3—lung cancer	5.78e-06	5.47e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—ALB—lung cancer	5.76e-06	5.45e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PPP2R1B—lung cancer	5.75e-06	5.44e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GSTT1—lung cancer	5.61e-06	5.31e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—AKR1C1—lung cancer	5.59e-06	5.29e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GCLC—lung cancer	5.55e-06	5.25e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CYP2A6—lung cancer	5.55e-06	5.25e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	5.44e-06	5.15e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—UGT1A1—lung cancer	5.43e-06	5.14e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ENO1—lung cancer	5.26e-06	4.98e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—CREBBP—lung cancer	5.25e-06	4.97e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GNG11—lung cancer	5.24e-06	4.96e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—lung cancer	5.21e-06	4.93e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PIK3CB—lung cancer	5.09e-06	4.82e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PTGS2—lung cancer	5.04e-06	4.77e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ALDOA—lung cancer	4.99e-06	4.72e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—ALB—lung cancer	4.92e-06	4.65e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—NCOA3—lung cancer	4.84e-06	4.58e-05	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—MAPK3—lung cancer	4.83e-06	4.57e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	4.76e-06	4.5e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CYP2E1—lung cancer	4.71e-06	4.46e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ADCY1—lung cancer	4.71e-06	4.46e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ABCG2—lung cancer	4.71e-06	4.46e-05	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—MYC—lung cancer	4.7e-06	4.45e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—NQO1—lung cancer	4.66e-06	4.41e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—HPGDS—lung cancer	4.62e-06	4.37e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ENO2—lung cancer	4.62e-06	4.37e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PPP2R1B—lung cancer	4.59e-06	4.34e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—POMC—lung cancer	4.53e-06	4.29e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GSTT1—lung cancer	4.48e-06	4.24e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—RAF1—lung cancer	4.45e-06	4.21e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GCLC—lung cancer	4.43e-06	4.19e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CYP2A6—lung cancer	4.43e-06	4.19e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	4.41e-06	4.17e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PTEN—lung cancer	4.4e-06	4.16e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—STK11—lung cancer	4.2e-06	3.98e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ENO1—lung cancer	4.2e-06	3.97e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—EP300—lung cancer	4.19e-06	3.97e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	4.18e-06	3.96e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—lung cancer	4.13e-06	3.91e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GSTP1—lung cancer	3.89e-06	3.68e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CAT—lung cancer	3.78e-06	3.58e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CYP2E1—lung cancer	3.76e-06	3.56e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—NQO1—lung cancer	3.72e-06	3.52e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	3.64e-06	3.45e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—TYMS—lung cancer	3.61e-06	3.42e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	3.61e-06	3.42e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GSTM1—lung cancer	3.57e-06	3.38e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CYP1A1—lung cancer	3.39e-06	3.21e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ERCC2—lung cancer	3.36e-06	3.18e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—STK11—lung cancer	3.35e-06	3.18e-05	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—AKT1—lung cancer	3.26e-06	3.08e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	3.15e-06	2.98e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GSTP1—lung cancer	3.1e-06	2.94e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PIK3CA—lung cancer	3.1e-06	2.94e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CAT—lung cancer	3.02e-06	2.86e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	3e-06	2.84e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ABCB1—lung cancer	2.94e-06	2.78e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—APOA1—lung cancer	2.91e-06	2.75e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—TYMS—lung cancer	2.89e-06	2.73e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GSTM1—lung cancer	2.85e-06	2.7e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CYP1A1—lung cancer	2.7e-06	2.56e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ERCC2—lung cancer	2.68e-06	2.54e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PIK3CG—lung cancer	2.65e-06	2.51e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—AKT1—lung cancer	2.53e-06	2.4e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—POMC—lung cancer	2.53e-06	2.39e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CREBBP—lung cancer	2.46e-06	2.33e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PIK3CD—lung cancer	2.33e-06	2.21e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—APOA1—lung cancer	2.32e-06	2.2e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ALB—lung cancer	2.3e-06	2.18e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.22e-06	2.1e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PIK3CG—lung cancer	2.12e-06	2e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PIK3CB—lung cancer	2.03e-06	1.92e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—POMC—lung cancer	2.02e-06	1.91e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PTGS2—lung cancer	2.01e-06	1.91e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CREBBP—lung cancer	1.96e-06	1.86e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PIK3CD—lung cancer	1.86e-06	1.76e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ALB—lung cancer	1.84e-06	1.74e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PTEN—lung cancer	1.76e-06	1.66e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—EP300—lung cancer	1.68e-06	1.59e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PIK3CB—lung cancer	1.62e-06	1.54e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PTGS2—lung cancer	1.61e-06	1.52e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PTEN—lung cancer	1.4e-06	1.33e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—EP300—lung cancer	1.34e-06	1.27e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PIK3CA—lung cancer	1.24e-06	1.17e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—AKT1—lung cancer	1.01e-06	9.58e-06	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PIK3CA—lung cancer	9.89e-07	9.36e-06	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—AKT1—lung cancer	8.08e-07	7.65e-06	CbGpPWpGaD
